close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

204.31 -2.73 (-1.32%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Insulet Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
Insulet (PODD): 3 Reasons We Love This Stock
What a brutal six months it’s been for Insulet. The stock has dropped 33.8% and now trades at $204.57, rattling many shareholders. This may have investors wo... 
Via StockStory
News headline image
Eli Lilly Secures Landmark FDA Approval for Oral Weight-Loss Pill, Sending Shares Soaring
Shares of Eli Lilly and Company (NYSE: LLY) surged 3.8% on Wednesday following the milestone FDA approval of Foundayo (orforglipron), the first once-daily oral weight-loss pill that does not require... 
Via MarketMinute
Topics Economy
Insulet Corp (NASDAQ:PODD): A Prime GARP Investment with Strong Growth and Reasonable Valuation ↗
Via Chartmill
What's going on in today's pre-market session: S&P500 movers ↗
Via Chartmill
Discover the top S&P500 movers in Thursday's after-hours session. ↗
Via Chartmill
Insulet Corp (NASDAQ:PODD): A High-Growth Stock Forming a Technical Base ↗
Via Chartmill
Insulet Corp. (NASDAQ:PODD) Reports Strong Q4 Earnings Beat Amid Mixed 2026 Guidance ↗
Via Chartmill
Topics Earnings
News headline image
Winners And Losers Of Q4: Insulet (NASDAQ:PODD) Vs The Rest Of The Patient Monitoring Stocks
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the patient monitoring stocks, including Insulet (NASDAQ:PODD) and its peers. Patient m... 
Via StockStory
Topics Artificial Intelligence
News headline image
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in... 
Via StockStory
Topics Artificial Intelligence Government Stocks
News headline image
3 S&P 500 Stocks for Long-Term Investors
The S&P 500 (^GSPC) is full of established businesses, but only some continue to outperform the market. A few standout companies are thriving thanks to stron... 
Via StockStory
Topics Stocks
Stay informed with the top movers within the S&P500 index on Wednesday. ↗
Via Chartmill
News headline image
1 Healthcare Stock with Exciting Potential and 2 We Avoid
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva... 
Via StockStory
News headline image
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment ↗
EyePoint develops sustained-release treatments for retinal diseases, leveraging proprietary technology and strategic industry partnerships. 
Via The Motley Fool
News headline image
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement ↗
This medical technology firm delivers advanced noninvasive monitoring and automation solutions to healthcare providers worldwide. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
EXCLUSIVE: Just 5 Female CEOs In A 50-Stock ETF — C-Suite Execs Explain The Leadership Gap In Corporate America ↗
-link data-ticker=GOOGL data-exchange=NASDAQ href=https://www.benzinga.com/quote/GOOGL target=_blank rel=noopener>(NASDAQ: GOOGL), One week after we celebrated the International Women's day, here is a... 
Via Benzinga
Topics ETFs Stocks
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
Friday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
Friday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
Top S&P500 movers in Friday's pre-market session ↗
Via Chartmill
News headline image
1 Oversold Stock Set for a Comeback and 2 Facing Challenges
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds. 
Via StockStory
Topics Artificial Intelligence
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
Friday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
Which S&P500 stocks are moving on Thursday? ↗
Via Chartmill
News headline image
PODD Q4 Deep Dive: Type 2 Diabetes Expansion and Innovation Drive Outperformance
Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 31.2% year on year to $783.8 million. The company... 
Via StockStory
What's going on in today's session: S&P500 movers ↗
Via Chartmill
News headline image
Insulet (PODD) Shares Skyrocket, What You Need To Know
Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) jumped 5.6% in the afternoon session after the company posted strong fourth-quarter 2025 financial results that beat Wall Street's... 
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
Insulet (PODD) Shakes the Market with Q4 Earnings Beat as Omnipod 5 Dominance Continues
Insulet Corporation (NASDAQ:PODD) delivered a commanding performance in its fourth-quarter earnings report released today, February 18, 2026. The medical device leader announced an adjusted earnings... 
Via MarketMinute
Topics Earnings
Wednesday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
What's going on in today's pre-market session: S&P500 movers ↗
Via Chartmill
News headline image
Insulet (NASDAQ:PODD) Surprises With Q4 CY2025 Sales
Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 31.2% year on year to $783.8 million. The company expects... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today